You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 13, 2024

FOSCARNET SODIUM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


DrugPatentWatch® Litigation and Generic Entry Outlook for Foscarnet Sodium

A generic version of FOSCARNET SODIUM was approved as foscarnet sodium by FRESENIUS KABI USA on January 29th, 2021.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for FOSCARNET SODIUM?
  • What are the global sales for FOSCARNET SODIUM?
  • What is Average Wholesale Price for FOSCARNET SODIUM?
Drug patent expirations by year for FOSCARNET SODIUM
Recent Clinical Trials for FOSCARNET SODIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Peking University People's HospitalPhase 4
CttqPhase 4
City of Hope Medical Center

See all FOSCARNET SODIUM clinical trials

Pharmacology for FOSCARNET SODIUM
Medical Subject Heading (MeSH) Categories for FOSCARNET SODIUM

US Patents and Regulatory Information for FOSCARNET SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal FOSCARNET SODIUM foscarnet sodium INJECTABLE;INJECTION 216602-001 Mar 1, 2024 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Fresenius Kabi Usa FOSCARNET SODIUM foscarnet sodium INJECTABLE;INJECTION 212483-001 Jan 29, 2021 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Avet Lifesciences FOSCARNET SODIUM foscarnet sodium INJECTABLE;INJECTION 213807-001 Jun 5, 2023 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Beijing FOSCARNET SODIUM foscarnet sodium INJECTABLE;INJECTION 213987-001 Nov 29, 2023 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira FOSCARNET SODIUM foscarnet sodium INJECTABLE;INJECTION 077174-001 May 31, 2005 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.